Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study

Detalles Bibliográficos
Autores principales: Garratt, C, Packer, M, Colucci, W, Fisher, L, Massie, B, Teerlink, J, Young, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099676/
http://dx.doi.org/10.1186/cc2556
_version_ 1782326521222922240
author Garratt, C
Packer, M
Colucci, W
Fisher, L
Massie, B
Teerlink, J
Young, J
author_facet Garratt, C
Packer, M
Colucci, W
Fisher, L
Massie, B
Teerlink, J
Young, J
author_sort Garratt, C
collection PubMed
description
format Online
Article
Text
id pubmed-4099676
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40996762014-09-23 Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study Garratt, C Packer, M Colucci, W Fisher, L Massie, B Teerlink, J Young, J Crit Care Poster Presentation BioMed Central 2004 2004-03-15 /pmc/articles/PMC4099676/ http://dx.doi.org/10.1186/cc2556 Text en
spellingShingle Poster Presentation
Garratt, C
Packer, M
Colucci, W
Fisher, L
Massie, B
Teerlink, J
Young, J
Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title_full Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title_fullStr Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title_full_unstemmed Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title_short Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
title_sort development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the revive 1 study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099676/
http://dx.doi.org/10.1186/cc2556
work_keys_str_mv AT garrattc developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT packerm developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT colucciw developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT fisherl developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT massieb developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT teerlinkj developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study
AT youngj developmentofacomprehensivenewendpointfortheevaluationofnewtreatmentsforacutedecompensatedheartfailureresultswithlevosimendanintherevive1study

Ejemplares similares